Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Unchanged |
2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,642 16.000% |
0 (Unchanged) |
Filing History |
| 2024-08-19 4:05 pm Purchase |
2024-08-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,642 18.800% |
16,667 (+8.64%) |
Filing History |
| 2024-05-06 4:05 pm Sale |
2024-05-02 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 201,044 19.300% |
-3,333 (-1.63%) |
Filing History |
| 2024-03-19 4:10 pm Purchase |
2024-03-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 204,377 21.000% |
16,875 (+9.00%) |
Filing History |
| 2024-03-15 12:15 pm Purchase |
2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 192,975 20.000% |
18,113 (+10.36%) |
Filing History |
| 2024-03-15 12:13 pm Purchase |
2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 187,502 19.500% |
18,113 (+10.69%) |
Filing History |
| 2024-03-06 5:05 pm Purchase |
2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 169,389 18.300% |
10,833 (+6.83%) |
Filing History |
| 2024-03-06 5:03 pm Purchase |
2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 174,862 18.900% |
10,833 (+6.60%) |
Filing History |
| 2024-02-07 5:29 pm Purchase |
2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Gruber Michele | 45,625 5.500% |
1,458 (+3.30%) |
Filing History |
| 2024-01-25 4:06 pm Unchanged |
2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Huang Leaf | 69,445 9.600% |
0 (Unchanged) |
Filing History |
| 2024-01-03 4:59 pm Purchase |
2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 72,477 11.000% |
72,477 (New Position) |
Filing History |
| 2023-06-21 5:07 pm Purchase |
2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 164,029 20.800% |
14,104 (+9.41%) |
Filing History |
| 2023-06-21 5:05 pm Purchase |
2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 158,555 20.100% |
14,104 (+9.76%) |
Filing History |
| 2023-03-29 3:02 pm Purchase |
2023-03-19 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Gruber Michele | 44,167 5.800% |
44,167 (New Position) |
Filing History |
| 2023-02-09 3:31 pm Purchase |
2022-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
Huang Leaf | 69,445 9.700% |
69,445 (New Position) |
Filing History |
| 2022-12-29 5:20 pm Purchase |
2022-12-19 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 144,451 18.600% |
144,451 (New Position) |
Filing History |
| 2022-12-29 5:18 pm Purchase |
2022-12-19 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 149,925 19.300% |
149,925 (New Position) |
Filing History |